Evidence map›Paper›PMID 37551214›Full record

ArticleCureus2023

Central Diabetes Insipidus in a Patient With Lymphoma: A Case Report.

Epameinondas Koumpis, Lydia Kyriazopoulou, Stelios Tigas, Eleni Kapsali, Eleftheria Hatzimichael

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Epameinondas KoumpisDepartment of Hematology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, GRC.
Lydia KyriazopoulouDepartment of Hematology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, GRC.
Stelios TigasDepartment of Endocrinology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, GRC.
Eleni KapsaliDepartment of Hematology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, GRC.
Eleftheria HatzimichaelDepartment of Hematology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, GRC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary central nervous system (CNS) lymphoma or systemic non-Hodgkin lymphoma that infiltrates the CNS can cause central diabetes insipidus (CDI). Polyuria and polydipsia should raise the suspicion of CDI development in patients with lymphoma that infiltrates the CNS. CDI is effectively treated with desmopressin. However, careful monitoring of the patient's serum sodium, fluid intake, urine output, and weight is necessary because patients receiving desmopressin may develop hyponatremia, so they should be alert to recognize this side effect promptly. Moreover, CDI due to lymphoma can occasionally be reversible. Therefore, the dosage of desmopressin should be adapted during or after the treatment of lymphoma.

Indexed as

central diabetes insipidusdlbclhypernatremialymphomaneurolymphomatosis

Identifiers

PMID37551214
PMCPMC10404345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.